Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000249316 | SCV000320493 | benign | Cardiovascular phenotype | 2023-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000479313 | SCV000570754 | likely benign | not provided | 2020-11-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000865251 | SCV001006187 | likely benign | Brugada syndrome 4 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001844103 | SCV002104133 | likely benign | not specified | 2022-02-05 | criteria provided, single submitter | clinical testing |